跳至主要内容
临床试验/NCT04119765
NCT04119765已完成不适用

Plasma Oxalate in Patient With Short Bowel

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2020年2月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
47
试验地点
1
主要终点
Plasma oxalate rate (oxalemia)

研究概览

简要总结

Hyperoxaluria due to fat malabsorption is seen in patients suffering from short bowel and can lead to stones and nephrocalcinosis. Not all patients are prone to these renal complications. only urinary oxaluria is measured in practice. Plasma oxalate shouldn't increase theoretically in these patients. However recent report showed an increase of plasma oxalate in patient with enteric hyperoxaluria. The aim of this study is to assess the plasma oxalate distribution in this specific population to have a new tool to predict renal complication of these patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Type II short bowel for more than 6 months
  • Affiliated to a social health care

排除标准

  • Primary hyperoxaluria
  • Other type of short bowel than type II
  • Minor patient or major patient protected by the law

结局指标

主要结局

Plasma oxalate rate (oxalemia)

时间窗: at inclusion

this sample measures the plasma oxalate rate

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验